Coca-Cola Europacific Partners vs Coca Cola
CCEP and KO side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CCEP and KO compare
Coca Cola grew revenue faster over the last twelve months (7.1% versus 2.3% for Coca-Cola Europacific Partners).
Coca Cola keeps more of each dollar of sales as profit, with a net margin of 28.7% compared with 9.3% at Coca-Cola Europacific Partners.
Coca Cola pays a dividend yielding 2.2%; Coca-Cola Europacific Partners does not pay one.
Coca Cola scores higher on the StockData Score (21 against 10 for Coca-Cola Europacific Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CCEP | KO |
|---|---|---|
| Size and price | ||
| Market cap | – | $419B |
| Share price | $116.93 | $97.44 |
| Change, 1 year | 25.5% | 36.1% |
| Change, 5 years | 126% | 76.7% |
| Beta (5Y) | 0.50 | 0.33 |
| Employees | 39K | 70K |
| StockData Score | ||
| Total score | 10 | 21 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 5 (better) |
| Performance score | 6 | 6 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 28.7× |
| P/S | – | 8.2× |
| P/B | – | 11.2× |
| EV/EBITDA | – | 27.5× |
| P/FCF | – | 29.4× |
| PEG | – | 2.48 |
| FCF yield | – | 3.4% |
| Fair value | – | $75.18 |
| Margin of safety | – | −29.6% |
| Growth | ||
| Revenue growth (TTM) | 2.3% | 7.1% (better) |
| Revenue growth, 5Y average | 14.5% (better) | 7.7% |
| Net income growth (TTM) | 37.0% (better) | 12.3% |
| EPS growth (TTM) | 38.3% (better) | 12.6% |
| EPS growth, 5Y average | 31.3% (better) | 11.2% |
| Profitability | ||
| Gross margin | 35.6% | 62.3% (better) |
| Operating margin | 13.4% | 30.0% (better) |
| Net margin | 9.3% | 28.7% (better) |
| FCF margin | 10.5% | 28.0% (better) |
| Return on equity | 23.8% | 42.6% (better) |
| Return on invested capital | 12.0% | 19.5% (better) |
| Financial health | ||
| Debt / equity | 1.36 | 1.11 (better) |
| Net debt / EBITDA | 3.50 | 1.70 (better) |
| Interest coverage | 9.1× | 10.0× (better) |
| Current ratio | 0.80 | 1.38 (better) |
| Altman Z-score | – | 5.83 |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 2.2% |
| Payout ratio | – | 76.8% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 4.5% |
| Buyback yield | – | 0.14% |
| Shareholder yield | – | 2.3% |
| Ownership | ||
| Held by institutions | 34.4% | 75.3% |
| Held by insiders | 17.6% | 0.22% |
| Insider net buying, 12 months | – | −$248M |
| Superinvestors holding | – | 5 |
| Short interest, % of float | – | 1.1% |
Go deeper
- CCEP stock overview
- CCEP income statement
- CCEP valuation and score
- KO stock overview
- KO income statement
- KO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.